Loading…
Joe Fiandra Access to Home Infusion Act of 2025
Legislative Progress
Introduced
August 19, 2025
Latest Action
December 10, 2025
Primary Sponsor
Brian K. FitzpatrickRepublican(PA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
91pct
113d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
Joe Fiandra Access to Home Infusion Act of 2025 This bill provides for Medicare coverage of certain home infusion drugs that are administered by health care professionals at a beneficiary’s home. Specifically, the bill provides for coverage of external infusion pumps and associated home infusion drugs for which (1) the prescription requires that the drug be administered by or under the supervision of a health care professional, (2) a qualified home infusion therapy supplier administers or supervises the administration of the drug at the beneficiary's home, and (3) the prescription requires that the drug be infused at least 12 times per year in a manner that requires the use of an external infusion pump.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2026 · third_quarter · Medicare/Medicaid
Implementation of HR 4993 the Joe Fiandra Access to Home Infusion Act, including issues in CMS-1828-P; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.
Committee Consideration and Mark-up Session Held
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Medicare/Medicaid
Issues related to the implementation of the Inflation Reduction Act; HR.4993, Joe Fiandra Access to Home Infusion Act; issues related to MFN drig pricing
Client expense: $470,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Issues related to the implementation of the Inflation Reduction Act; HR.4993, Joe Fiandra Access to Home Infusion Act; issues related to MFN drig pricing
Client expense: $450,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Implementation of HR 4993 the Joe Fiandra Access to Home Infusion Act, including issues in CMS-1828-P; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Issues related to home health, community-based services, behavioral health, adoption of electronic health records, and telehealth, generally, issues related to AI and digital health, generally; hospital at home, generally; H.R. 5371, The Continuing Appropriations and Extensions Act, 2026, issues related to health care, generally; S.2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026, issues related to health care, generally; H.R.5142, Home Health Stabilization Act of 2025; H.R.4313/S.2237, Hospital Inpatient Services Modernization Act; H.R.4206/S.1261, CONNECT for Health Act of 2025; H.R.4993, Joe Fiandra Access to Home Infusion Act of 2025.
Client expense: Not reported · Firm income: $90,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
HR 4993 the Joe Fiandra Access to Home Infusion Act; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines; HR 7148 the Consolidated Appropriations Act of 2026
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
Issues related to the implementation of the Inflation Reduction Act; HR.4993, Joe Fiandra Access to Home Infusion Act; issues related to MFN drig pricing
Client expense: $430,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
Issues related to home health, community-based services, behavioral health, adoption of electronic health records, and telehealth, generally, issues related to AI and digital health, generally; hospital at home, generally; H.R. 5371, The Continuing Appropriations and Extensions Act, 2026, issues related to health care, generally; S.2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026, issues related to health care, generally; issues related to the CMS Digital Health Pledge; H.R.5142, Home Health Stabilization Act of 2025; H.R.4313, Hospital Inpatient Services Modernization Act; H.R.4206, CONNECT for Health Act of 2025; H.R.4993, Joe Fiandra Access to Home Infusion Act of 2025
Client expense: Not reported · Firm income: $90,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2025 · fourth_quarter · Medicare/Medicaid
HR 4993 the Joe Fiandra Access to Home Infusion Act; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Medicare/Medicaid
Issues related to the implementation of the Inflation Reduction Act; HR.4993, Joe Fiandra Access to Home Infusion Act
Client expense: $390,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
HR 4993 - Joe Fiandra Access to Home Infusion Act of 2025 HR 4317 - PBM Reform Act of 2025
Client expense: $350,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2025 · third_quarter · Medicare/Medicaid
Issues related to the implementation of the Inflation Reduction Act; HR.4993, Joe Fiandra Access to Home Infusion Act
Client expense: $390,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Medicare/Medicaid
HR 4993 the Joe Fiandra Access to Home Infusion Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
HR 4993 - Joe Fiandra Access to Home Infusion Act
Client expense: $340,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Marine/Maritime/Boating/Fisheries
H.R. 4993 Expanding eligibility of Capital Construction Funds for acquisition of cargo handling equipment.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Marine/Maritime/Boating/Fisheries
H.R. 4993 Expanding eligibility of Capital Construction Funds for acquisition of cargo handling equipment.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| NJ |
| Michael Lawler | Republican | NY |
| Neal P. Dunn | Republican | FL |